SCHEMBL4900641

SCHEMBL4900641

Cc1ccc(S(=O)(=O)N(CCc2ccc(OCc3ccc(Cl)cc3)cc2)Cc2ccc(Cl)cc2)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
POLB P06746 1/20 0.54
CA12 O43570 3/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA4 P22748 3/20 0.49
CA9 Q16790 3/20 0.49
TAS2R14 Q9NYV8 4/20 0.49
PTGES O14684 2/20 0.47
KCNH2 Q12809 1/20 0.47
DAGLA Q9Y4D2 1/20 0.45
NR1H4 Q96RI1 1/20 0.44
NR4A2 P43354 1/20 0.44
CXCR3 P49682 1/20 0.43
STAT3 P40763 1/20 0.43
CNR2 P34972 1/20 0.43
TP53 P04637 1/20 0.43
THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905775 0.92 TAS2R14 (0.58) MEN1KMT2APOLBCA12CA1
SCHEMBL4904466 0.92 CNR2 (0.53) MEN1KMT2APOLBCA12CA1
SCHEMBL4902732 0.91 KMT2A (0.48) MEN1KMT2APOLBCA12CA1
SCHEMBL4908668 0.91 TAS2R14 (0.49) MEN1KMT2APOLBCA12CA1
SCHEMBL4894471 0.88 CA12 (0.48) CA12CA1CA2CA4CA9
SCHEMBL4898092 0.88 TAS2R14 (0.48) MEN1KMT2APOLBCA12CA1
SCHEMBL4897933 0.87 TAS2R14 (0.46) MEN1KMT2APOLBCA12CA1
SCHEMBL4906541 0.86 TAS2R14 (0.46) MEN1KMT2APOLBCA12CA1
SCHEMBL4895626 0.84 TAS2R14 (0.56) MEN1KMT2APOLBCA12CA1
SCHEMBL4908413 0.83 CNR2 (0.48) CA12CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885POLB 1807/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.